纵横研报
Tag

#Compounding

03Reports
·检测与认证服务 ·In-house Research

SGS: High-Quality TIC Compounder at Full Value

SGS SA is the world's broadest publicly listed testing, inspection and certification group, monetizing accreditation, network density and a century-old reputation for independence across more than 2,500 facilities in 115 countries. In 2025 it generated CHF 6.945 billion of sales at a 16.0% adjusted operating margin and converted profit to cash at roughly 1.9x net income, yet at about 25.9x trailing earnings and a 3.6% dividend yield the market already prices the Strategy 27 reacceleration, leaving no conservative margin of safety against a CHF 80-84 fair value. Rating Hold: a high-quality TIC compounder whose current price captures most of the Strategy 27 improvement and leaves limited conservative upside.

Hold
·软件与互联网 ·In-house Research

Constellation Software: A Compounding Machine at a Full Price

Constellation Software is a decentralized capital-allocation machine that buys and indefinitely holds more than 1,100 autonomous vertical-market software businesses, compounding sticky recurring maintenance cash flow into further niche acquisitions across nine operating groups. The investment debate is now about price and continuity, not quality: Q1 2026 revenue rose 20% to US$3.181 billion with 6% organic growth and free cash flow available to shareholders of US$733 million, yet at CA$2,882.02 the stock trades near 58.7 times trailing earnings and 22.9 times that cash flow while founder Mark Leonard's 2025 departure and AI fears cloud the outlook. Rating Hold: a rare software compounding machine, but today's price still assumes enough continuity that the margin of safety is thin.

Hold
·检测与认证服务 ·In-house Research

Bureau Veritas: Quality TIC, Priced for Reacceleration

Bureau Veritas is an 1828-founded global testing, inspection and certification network operating across six lines that sells institutional trust, with 2025 revenue of EUR 6.47 billion, a 16.3% adjusted operating margin, and EUR 824 million of free cash flow. The real question is durability rather than quality: after a strong 2024 of 10.2% organic growth, Q1 2026 organic growth slowed to 4.5% and management trimmed full-year guidance on Government Services contract exits, leaving the stock at about 18.4x 2025 adjusted EPS of EUR 1.42 with a conservative fair value near EUR 23 already below the current EUR 26.16 price. Rating Hold: Bureau Veritas remains a strong TIC franchise, but the current price already discounts much of the LEAP 28 plan before 2026 re-acceleration is proven.

Hold